Default company panoramic image
D82b6252 b805 4f03 94f5 f44c484d88ed

Phlebotics, Inc.

Development of programmable serial blood sampler for infusion clinics, ICUs, clinical trials & medical research. Less waste, risk, labor.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location West Lafayette, IN, USA
  • Currency USD
  • Founded September 2007
  • Employees 0

Company Summary

Phlebotics has developed a novel medical device that automatically samples small amounts of blood from catheter lines for a broad range of diagnostics or therapeutic purposes (trials, infusion clinics, or ICUs for all ages). The concept has been proven and used many times in the animal market by BASi of West Lafayette, IN. Phlebotics will expand into the human market and has all contractual rights and underlying IP to secure its unique position.

Team

  • Default avatar
    Peter Thomas Kissinger
    Chm/CEO

    Serial entrepreneur and bioanalytical chemistry academic at Purdue University. Active advisor and board member to diagnostic, medical device and scientific instrument businesses. Private and public firms. Special interests in pharmacology and applications of mass spectrometry, chromatography and electrochemical sensors.

  • Default avatar
    Candice Brenda Kissinger
    Founder; Chief Scientific Officer

    Experienced entrepreneur; led team that developed first preclinical automated blood sampler, Culex, and sold globally to pharma/biotech research. Earlier, she first commercialized microdialysis in vivo sampling in USA. Deep international experience.
    Has led contract research in preclinical pharmacology and drug metabolism (ADME). Established a translational pharmacology unit at Purdue University.

  • Default avatar
    Nancy Lonsinger
    S&M Advisor

    Nancy Lonsinger, Marketing and Sales specialist with a deep background in diabetes monitoring marketing and in supporting healthcare start-up businesses

  • Default avatar
    Joerg Schreiber
    COO Advisor

    Joerg Schreiber, Ph.D., advising COO, serial entrepreneur with 25 years experience in commercializing medical devices

Advisors

  • Default avatar
    Dan Boeglin, Faegre Baker Daniels
    Lawyer
    Unconfirmed
    Default avatar
    Jim Schulz, Milestone Advisors
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    NIH grant: $1.25 Million
    Unconfirmed
    Default avatar
    Pete & Candice Kissinger: $400,000
    Unconfirmed